Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

Hans Wedel, John J. V. McMurray, Magnus Lindberg, John Wikstrand, John G. F. Cleland, Jan H. Cornel, Peter Dunselman, Ake Hjalmarson, John Kjekshus, Michel Komajda, Timo Kuusi, Johan Vanhaecke, Finn Waagstein, CORONA Study Grp

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalEuropean Journal of Heart Failure
Volume11
Issue number3
Pages (from-to)281-291
Number of pages11
ISSN1388-9842
DOIs
Publication statusPublished - Mar 2009
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Chronic heart failure
  • RENAL-FUNCTION
  • PROGNOSTIC VALUE
  • MORTALITY
  • MODEL
  • MORBIDITY
  • SURVIVAL
  • THERAPY
  • CHOLESTEROL
  • VALIDATION
  • VALSARTAN
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this